SQZ Biotechnologies Co (SQZ) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 40 transactions totaling $45.5M, demonstrating a bullish sentiment with $45.5M in net insider flow. The most recent transaction on Aug 15, 2022 involved a sale of 1,183 shares valued at $3.9K.
No significant insider buying has been recorded for SQZ in the recent period.
No significant insider selling has been recorded for SQZ in the recent period.
Based on recent SEC filings, insider sentiment for SQZ is bullish with an Insider Alignment Score of 100/100 and a net flow of $45.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at SQZ Biotechnologies Co (SQZ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading SQZ stock, having executed 40 transactions in the past 90 days. The most active insider is International Group Inc American (Executive), who has made 8 transactions totaling $20.0M.
Get notified when executives and directors at SQZ file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Capasso Richard | Executive | Sale | 1,183 | $3.33 | $3.9K | |
| Jun 30, 2022 | Capasso Richard | Executive | Award | 1,183 | $2.70 | $3.2K | |
| Jun 30, 2022 | J. Knopf Lawrence | Executive | Award | 1,484 | $2.70 | $4.0K | |
| Jun 30, 2022 | Sharei Armon | Executive | Award | 2,436 | $2.70 | $6.6K | |
| May 25, 2022 | F. Jensen Klavs | Executive | Purchase | 14,326 | $3.52 | $50.4K | |
| Jan 12, 2022 | Sharei Armon | Executive | Option Exercise | 13,000 | $1.81 | $23.5K | |
| Dec 31, 2021 | J. Knopf Lawrence | Executive | Award | 454 | $7.59 | $3.4K | |
| Dec 31, 2021 | Sharei Armon | Executive | Award | 1,686 | $7.59 | $12.8K | |
| Dec 22, 2021 | Sharei Armon | Executive | Option Exercise | 11,049 | $1.81 | $20.0K | |
| Dec 22, 2021 | W. Schulman Amy | Executive | Option Exercise | 7,458 | $4.59 | $34.2K | |
| Dec 22, 2021 | W. Schulman Amy | Executive | Option Exercise | 6,581 | $4.59 | $30.2K | |
| Dec 22, 2021 | W. Schulman Amy | Executive | Option Exercise | 10,091 | $2.02 | $20.4K | |
| Dec 13, 2021 | W. Schulman Amy | Executive | Purchase | 1,850 | $10.94 | $20.2K | |
| Dec 13, 2021 | W. Schulman Amy | Executive | Purchase | 1,850 | $10.88 | $20.1K | |
| Feb 27, 2021 | Sharei Armon | Executive | Option Exercise | 8,000 | $1.81 | $14.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 11 | $45.5M | 99.6% |
Exercise(M) | 7 | $147.4K | 0.3% |
Award(A) | 5 | $30.0K | 0.1% |
Sale(S) | 1 | $3.9K | 0.0% |
Conversion(C) | 16 | $0 | 0.0% |
Insiders at SQZ Biotechnologies Co are accumulating shares at an accelerated pace. With 10 insiders making 40 transactions totaling $45.5M in purchases versus $3.9K in sales, the net buying activity of $45.5M signals strong executive confidence. International Group Inc American (Executive) leads the buying activity with $20.0M in transactions across all time.